AAAAAA

   
Results: 1-12 |
Results: 12

Authors: SCHINCO P BORCHIELLINI A TAMPONI G MONTARULI B GARIS G BAZZAN M PANNOCCHIA A MODENA V PILERI A
Citation: P. Schinco et al., LUPUS ANTICOAGULANT AND THROMBOSIS - ROLE OF VON-WILLEBRAND-FACTOR MULTIMERIC FORMS, Clinical and experimental rheumatology, 15(1), 1997, pp. 5-10

Authors: BAZZAN M TAMPONI G VACCARINO A MONTARULI B ALUFFI E SCHINCO P PANNOCCHIA A BORCHIELLINI A RABBIA C PILERI A
Citation: M. Bazzan et al., NATURAL AND ACQUIRED INHIBITORS OF HEMOSTASIS IN SELECTED SYMPTOMATICOUTPATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE, Haematologica, 82(4), 1997, pp. 420-422

Authors: MONTARULI B PANNOCCHIA A SCHINCO P BAZZAN M GIORGIANNI A BORCHIELLINI A VACCARINO A TAMPONI G
Citation: B. Montaruli et al., RESISTANCE TO ACTIVATED PROTEIN-C EVALUATED WITH A FACTOR V-PHOSPHOLIPID MODIFIED TEST, Thrombosis and haemostasis, 1997, pp. 90-90

Authors: SCHINCO PC MONTARULI B BORCHIELLINI A TAMPONI G
Citation: Pc. Schinco et al., EFFICACY AND SAFETY OF HIGH-DOSE PORCINE F.VIII DURING HIGH-DOSE CHEMOTHERAPY (HDCT) AND AUTOBMT IN A HEMOPHILIAC WITH NHL, Thrombosis and haemostasis, 1997, pp. 223-223

Authors: MONTARULI B SCHINCO P PANNOCCHIA A GIORGIANNI A BORCHIELLINI A TAMPONI G PILERI A
Citation: B. Montaruli et al., USE OF MODIFIED FUNCTIONAL ASSAYS FOR ACTIVATED PROTEIN-C RESISTANCE IN PATIENTS WITH BASALLY PROLONGED APTT, Thrombosis and haemostasis, 78(3), 1997, pp. 1042-1048

Authors: MONTARULI B BORCHIELLINI A TAMPONI G GIORDA L BESSONE P VANMOURIK JA VOORBERG J SCHINCO P
Citation: B. Montaruli et al., FACTOR-V ARG(506)-]GLN MUTATION IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, Lupus, 5(4), 1996, pp. 303-306

Authors: MONTARULI B VOORBERG J TAMPONI G BORCHIELLINI A MULEO G PANNOCCHIA A VANMOURIK JA SCHINCO P
Citation: B. Montaruli et al., ARTERIAL AND VENOUS THROMBOSIS IN 2 ITALIAN FAMILIES WITH THE FACTOR-V ARG(506)-]GLN MUTATION, European journal of haematology, 57(1), 1996, pp. 96-100

Authors: BORCHIELLINI A FIJNVANDRAAT K TENCATE JW PAJKRT D VANDEVENTER SJH PASTERKAMP G MEIJERHUIZINGA F ZWARTHUININK L VOORBERG J VANMOURIK JA
Citation: A. Borchiellini et al., QUANTITATIVE-ANALYSIS OF VON-WILLEBRAND-FACTOR PROPEPTIDE RELEASE IN-VIVO - EFFECT OF EXPERIMENTAL ENDOTOXEMIA AND ADMINISTRATION OF 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN HUMANS, Blood, 88(8), 1996, pp. 2951-2958

Authors: SCHINCO P BORCHIELLINI A MONTARULI B TAMPONI G PILERI A
Citation: P. Schinco et al., SUPRANORMAL VON-WILLEBRAND-FACTOR MULTIMERS IN PATIENTS WITH LUPUS ANTICOAGULANT AND THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 950-950

Authors: SCHINCO P BORCHIELLINI A FRIERI R GARIS G TAMPONI G PILERI A
Citation: P. Schinco et al., VON-WILLEBRAND-FACTOR (VWF) BEHAVIOR DURING LONG-TERM ADMINISTRATION OF LOW-DOSE RINTERFERON-2-ALPHA (RIFN-2-ALPHA, Thrombosis and haemostasis, 69(6), 1993, pp. 950-950

Authors: SCHINCO P BORCHIELLINI A GARIS G TAMPONI G PILERI A
Citation: P. Schinco et al., MULTIMERIC ANALYSIS OF VONWILLEBRAND-FACTOR (VWF) IN PATIENTS WITH LUPUS ANTICOAGULANT (LA), Thrombosis research, 70, 1993, pp. 70-70

Authors: SCHINCO P TAMPONI G BORCHIELLINI A
Citation: P. Schinco et al., EFFICACY OF OCTREOTIDE AND DESMOPRESSIN IN REDUCING BLOOD-LOSS IN PATIENTS WITH ANGIODYSPLASIA, Thrombosis research, 70, 1993, pp. 157-157
Risultati: 1-12 |